Zomagen Biosciences

Technologiepark 94

9052 Gent

BE

Zomagen Biosciences

Foundation date

26/02/2020

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

Zomagen is a therapeutic product discovery & development biotech company focussed on compounds targeting the innate immune system, eventually to treat diseases with chronic inflammatory involvement.

Upcoming events

Latest news

  • UCB announces positive Phase 3 studies for bimekizumab in hidradenitis suppurativa

    1 day ago

  • Company growth prompts Connected-Pathology relocation to larger laboratory facilities to accommodate increase in study capacity

    Tuesday December 6th 2022

  • Japan welcomes companies, startups and knowledge institutions from Flanders

    Friday December 2nd 2022

Jobs by Zomagen Biosciences